human gene therapy
non-human primates
post-mortem human retinas
human post-mortem retinas
translational gene therapy
non-human primate retina
retinal degenerative disease Gene therapy
non-human primate models of retinal degeneration
novel AAVs
predictive of human outcome
retinal disease
pre-clinical animal models
small animal models
clinical need
clinical trials
creation of models
specific clinical trial
efficacy of viral delivery
transgenic primates
small animal studies
AAV capsid serotype selection
different AAV capsid pseudotypes
enhanced delivery properties
delivery of pathogenic genes
effects of therapies
murine retina
sight restoration
vision restoration
testing efficacy
Aim B
specific subsets of cells
adeno
major roadblock
macula
high central visual acuity
effectiveness
use
prosthesis
early promise
neuroprotection
pathology
vectors
development of ocular therapeutics
eye diseases
directed evolution
germline transgenesis
present
rodents
Modeling
bioengineering approach
substantial progress
humans
unique transduction profile
therapeutic transgene cassette
bottlenecks